Unique ID issued by UMIN | UMIN000031079 |
---|---|
Receipt number | R000035384 |
Scientific Title | A multicenter prospective study of value of the bone scan index using a computer-aided diagnosis system for bone scans in prostate cancer with bone metastases. |
Date of disclosure of the study information | 2018/01/31 |
Last modified on | 2019/08/07 18:26:40 |
A multicenter prospective study of value of the bone scan index using a computer-aided diagnosis system for bone scans in prostate cancer with bone metastases.
BSI trial
A multicenter prospective study of value of the bone scan index using a computer-aided diagnosis system for bone scans in prostate cancer with bone metastases.
BSI trial
Japan |
prostate cancer with bone metastases
Urology |
Malignancy
NO
To evaluate the value of the bone scan index using a computer-aided diagnosis system for bone scans in prostate cancer with bone metastases.
Efficacy
Progression free survival
overall survival
Time to initiation of subsequent antineoplastic therapy
Three year progression free survival rates
Three year overall survival rates
Rates of initiation of subsequent antineoplastic therapy within three years
Observational
20 | years-old | <= |
Not applicable |
Male
1.Physician determined that the patient has ability to understand the trial.
2.Patient has signed the Informed Consent Form.
3.Histologically confirmed prostate cancer.
4.With bone metastases on bone scan.
5.Bone metastatic prostate cancer who had not previously received hormone therapy.
6.Patient who plan to undergo hormon therapy.
7.Patient who don't have a cancer except prostate cancer within 5 years before registration.
8.ECOG Performance Status 0-2
9.Patient must be 20 years or older at the time of Informed Consent.
10.Life expectancy>=6months at the time of Informed Consent.
1.Patient has active other cancers.
2.Patient has history of the severe hyper-sensitivity drug reaction.
3.Patient has severe disease.
4.Patient has disease which is not controlled properly in accordance with the protocol.
5.Physician determined that the patient was not appropriate as a candidate.
100
1st name | |
Middle name | |
Last name | Yasuhide Miyoshi |
Yokohama City University Medical Center
Department of Urology and Renal Transplantation
4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan
045-261-5656
miyoyasu@yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | Yasuhide Miyoshi |
Yokohama City University Medical Center
Department of Urology and Renal Transplantation
4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan
045-261-5656
miyoyasu@yokohama-cu.ac.jp
Yokohama City University Medical Center,
FUJIFILM RI Pharma Co.,Ltd.
Profit organization
NO
2018 | Year | 01 | Month | 31 | Day |
Unpublished
Enrolling by invitation
2017 | Year | 11 | Month | 28 | Day |
2018 | Year | 01 | Month | 25 | Day |
2018 | Year | 01 | Month | 31 | Day |
2024 | Year | 12 | Month | 31 | Day |
To evaluate the value of the bone scan index using a computer-aided diagnosis system for bone scans in prostate cancer with bone metastases.
2018 | Year | 01 | Month | 31 | Day |
2019 | Year | 08 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035384
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |